{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T21:12:14Z","timestamp":1792789934858,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,29]],"date-time":"2022-11-29T00:00:00Z","timestamp":1669680000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["31900547"],"award-info":[{"award-number":["31900547"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.heliyon.2022.e12130","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T20:38:25Z","timestamp":1670359105000},"page":"e12130","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases"],"prefix":"10.1016","volume":"8","author":[{"given":"Yaping","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongrong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miaomiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0172-189X","authenticated-orcid":false,"given":"Pengfei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.heliyon.2022.e12130_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.107168","article-title":"Recent advance of spleen tyrosine kinase in diseases and drugs","volume":"90","author":"Shao","year":"2021","journal-title":"Int. Immunopharm."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12130_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/nri2765","article-title":"The SYK tyrosine kinase: a crucial player in diverse biological functions","volume":"10","author":"Mocsai","year":"2010","journal-title":"Nat. Rev. Immunol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12130_bib3","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.kint.2019.12.014","article-title":"Spleen tyrosine kinase inhibition is an effective treatment for established vasculitis in a pre-clinical model","volume":"97","author":"McAdoo","year":"2020","journal-title":"Kidney Int."},{"issue":"23","key":"10.1016\/j.heliyon.2022.e12130_bib4","doi-asserted-by":"crossref","first-page":"16878","DOI":"10.1074\/jbc.M610494200","article-title":"Expression and mechanism of spleen tyrosine kinase activation by angiotensin II and its implication in protein synthesis in rat vascular smooth muscle cells","volume":"282","author":"Yaghini","year":"2007","journal-title":"J.\u00a0Biol. Chem."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12130_bib5","first-page":"2481","article-title":"Spleen tyrosine kinase-induced JNK-dependent NLRP3 activation is involved in diabetic cardiomyopathy","volume":"43","author":"Li","year":"2019","journal-title":"Int. J. Mol. Med."},{"issue":"22","key":"10.1016\/j.heliyon.2022.e12130_bib6","doi-asserted-by":"crossref","first-page":"4229","DOI":"10.1111\/febs.14665","article-title":"Spleen tyrosine kinase SYK(L) interacts with YY1 and coordinately suppresses SNAI2 transcription in lung cancer cells","volume":"285","author":"Gao","year":"2018","journal-title":"FEBS J."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12130_bib7","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1002\/hep.29881","article-title":"Tyrosine kinase SYK is a potential therapeutic target for liver fibrosis","volume":"68","author":"Qu","year":"2018","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12130_bib8","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1186\/ar3198","article-title":"Spleen tyrosine kinase inhibition in the treatment of autoimmune, allergic and autoinflammatory diseases","volume":"12","author":"Pamuk","year":"2010","journal-title":"Arthritis Res. Ther."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12130_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s13045-017-0512-1","article-title":"Syk inhibitors in clinical development for hematological malignancies","volume":"10","author":"Liu","year":"2017","journal-title":"J.\u00a0Hematol. Oncol."},{"issue":"23","key":"10.1016\/j.heliyon.2022.e12130_bib10","doi-asserted-by":"crossref","first-page":"4894","DOI":"10.1182\/blood-2010-03-275180","article-title":"The Syk inhibitor fostamatinib disodium (R788) inhibits tumor growth in the Emu- TCL1 transgenic mouse model of CLL by blocking antigen-dependent B-cell receptor signaling","volume":"116","author":"Suljagic","year":"2010","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12130_bib11","doi-asserted-by":"crossref","first-page":"3856","DOI":"10.1021\/jm500228a","article-title":"Discovery of GS-9973, a selective and orally efficacious inhibitor of spleen tyrosine kinase","volume":"57","author":"Currie","year":"2014","journal-title":"J.\u00a0Med. Chem."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12130_bib12","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1124\/jpet.114.218164","article-title":"The novel kinase inhibitor PRT062070 (Cerdulatinib) demonstrates efficacy in models of autoimmunity and B-cell cancer","volume":"351","author":"Coffey","year":"2014","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12130_bib13","doi-asserted-by":"crossref","first-page":"8120","DOI":"10.1038\/s41598-017-08689-1","article-title":"NLRP3 inflammasome activation results in liver inflammation and fibrosis in mice infected with Schistosoma japonicum in a Syk-dependent manner","volume":"7","author":"Lu","year":"2017","journal-title":"Sci. Rep."},{"issue":"11","key":"10.1016\/j.heliyon.2022.e12130_bib14","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1136\/gutjnl-2012-302615","article-title":"Inhibition of spleen tyrosine kinase as treatment of postoperative ileus","volume":"62","author":"van Bree","year":"2013","journal-title":"Gut"},{"key":"10.1016\/j.heliyon.2022.e12130_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.freeradbiomed.2021.08.241","article-title":"Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis","volume":"175","author":"Hu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12130_bib16","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1038\/s41419-021-04403-2","article-title":"Targeting SYK of monocyte-derived macrophages regulates liver fibrosis via crosstalking with Erk\/Hif1alpha and remodeling liver inflammatory environment","volume":"12","author":"Chen","year":"2021","journal-title":"Cell Death Dis."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12130_bib17","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3390\/antib6040023","article-title":"Modulation of BCR signaling by the induced dimerization of receptor-associated SYK","volume":"6","author":"Westbroek","year":"2017","journal-title":"Antibodies (Basel)"},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12130_bib18","doi-asserted-by":"crossref","first-page":"2584","DOI":"10.1093\/emboj\/17.9.2584","article-title":"A\u00a0unique insert in the linker domain of Syk is necessary for its function in immunoreceptor signalling","volume":"17","author":"Latour","year":"1998","journal-title":"EMBO J."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12130_bib19","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1158\/0008-5472.CAN-13-2104","article-title":"Expression of variant isoforms of the tyrosine kinase SYK determines the prognosis of hepatocellular carcinoma","volume":"74","author":"Hong","year":"2014","journal-title":"Cancer Res."},{"issue":"15","key":"10.1016\/j.heliyon.2022.e12130_bib20","first-page":"4724","article-title":"Alternative splicing disrupts a nuclear localization signal in spleen tyrosine kinase that is required for invasion suppression in breast cancer","volume":"63","author":"Wang","year":"2003","journal-title":"Cancer Res."},{"issue":"33","key":"10.1016\/j.heliyon.2022.e12130_bib21","doi-asserted-by":"crossref","first-page":"11760","DOI":"10.1073\/pnas.0708583105","article-title":"Tyr130 phosphorylation triggers Syk release from antigen receptor by long-distance conformational uncoupling","volume":"105","author":"Zhang","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12130_bib22","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1038\/s41588-021-00803-4","article-title":"Gain-of-function variants in SYK cause immune dysregulation and systemic inflammation in humans and mice","volume":"53","author":"Wang","year":"2021","journal-title":"Nat. Genet."},{"issue":"9","key":"10.1016\/j.heliyon.2022.e12130_bib23","doi-asserted-by":"crossref","first-page":"2351","DOI":"10.4049\/jimmunol.1901381","article-title":"The FcgammaRIIa-Syk Axis controls human dendritic cell activation and T cell response induced by Infliximab aggregates","volume":"205","author":"Nabhan","year":"2020","journal-title":"J.\u00a0Immunol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12130_bib24","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.jcmgh.2021.08.004","article-title":"SYK-3BP2 pathway activity in parenchymal and myeloid cells is a key pathogenic factor in metabolic steatohepatitis","volume":"13","author":"Luci","year":"2022","journal-title":"Cell Mol. Gastroenterol. Hepatol."},{"issue":"48","key":"10.1016\/j.heliyon.2022.e12130_bib25","doi-asserted-by":"crossref","first-page":"6046","DOI":"10.3748\/wjg.v16.i48.6046","article-title":"Regulation of hepatic blood flow: the hepatic arterial buffer response revisited","volume":"16","author":"Eipel","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e12130_bib26","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1007\/s00535-015-1054-3","article-title":"Migration of splenic lymphocytes promotes liver fibrosis through modification of T helper cytokine balance in mice","volume":"50","author":"Tanabe","year":"2015","journal-title":"J.\u00a0Gastroenterol."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12130_bib27","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12967-017-1214-8","article-title":"The spleen in liver cirrhosis: revisiting an old enemy with novel targets","volume":"15","author":"Li","year":"2017","journal-title":"J.\u00a0Transl. Med."},{"issue":"17","key":"10.1016\/j.heliyon.2022.e12130_bib28","doi-asserted-by":"crossref","first-page":"10341","DOI":"10.1016\/S0021-9258(17)44462-0","article-title":"Tyrosine protein kinase activity of rat spleen and other tissues","volume":"258","author":"Swarup","year":"1983","journal-title":"J.\u00a0Biol. Chem."},{"issue":"7527","key":"10.1016\/j.heliyon.2022.e12130_bib29","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/nature13992","article-title":"A\u00a0comparative encyclopedia of DNA elements in the mouse genome","volume":"515","author":"Yue","year":"2014","journal-title":"Nature"},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12130_bib30","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1080\/17474124.2021.1914587","article-title":"Liver-spleen axis in nonalcoholic fatty liver disease","volume":"15","author":"Tarantino","year":"2021","journal-title":"Expet Rev. Gastroenterol. Hepatol."},{"issue":"18","key":"10.1016\/j.heliyon.2022.e12130_bib31","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1080\/10408398.2017.1353479","article-title":"Nutrition, inflammation and liver-spleen axis","volume":"58","author":"Barrea","year":"2018","journal-title":"Crit. Rev. Food Sci. Nutr."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12130_bib32","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1002\/jso.25577","article-title":"Is synchronous hepatectomy and splenectomy superior to hepatectomy alone for selected patients with hepatocellular carcinoma and clinically significant portal hypertension?","volume":"120","author":"Xie","year":"2019","journal-title":"J.\u00a0Surg. Oncol."},{"issue":"133","key":"10.1016\/j.heliyon.2022.e12130_bib33","first-page":"1363","article-title":"Synchronous splenectomy and hepatectomy in patients with hepatocellular carcinoma, hypersplenism and liver cirrhosis","volume":"61","author":"Shi","year":"2014","journal-title":"Hepato-Gastroenterology"},{"key":"10.1016\/j.heliyon.2022.e12130_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106762","article-title":"Splenectomy enhances the Ly6C(low) phenotype in hepatic macrophages by activating the ERK1\/2 pathway during liver fibrosis","volume":"86","author":"Zheng","year":"2020","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.heliyon.2022.e12130_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2020.106420","article-title":"Spleen contributes to restraint stress induced hepatocellular carcinoma progression","volume":"83","author":"Jiang","year":"2020","journal-title":"Int. Immunopharm."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12130_bib36","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1038\/s12276-021-00574-2","article-title":"Splenectomy improves liver fibrosis via tumor necrosis factor superfamily 14 (LIGHT) through the JNK\/TGF-beta1 signaling pathway","volume":"53","author":"Liang","year":"2021","journal-title":"Exp. Mol. Med."},{"issue":"21","key":"10.1016\/j.heliyon.2022.e12130_bib37","doi-asserted-by":"crossref","first-page":"7771","DOI":"10.1073\/pnas.1402914111","article-title":"Tracking of intertissue migration reveals the origins of tumor-infiltrating monocytes","volume":"111","author":"Shand","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"issue":"21","key":"10.1016\/j.heliyon.2022.e12130_bib38","doi-asserted-by":"crossref","first-page":"5318","DOI":"10.3390\/cancers13215318","article-title":"Targeting tumor-associated macrophages in cancer immunotherapy","volume":"13","author":"Petty","year":"2021","journal-title":"Cancers"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12130_bib39","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1038\/s41392-021-00506-6","article-title":"Targeting macrophages in cancer immunotherapy","volume":"6","author":"Duan","year":"2021","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.heliyon.2022.e12130_bib40","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jconrel.2018.09.004","article-title":"Therapeutic inhibition of spleen tyrosine kinase in inflammatory macrophages using PLGA nanoparticles for the treatment of non-alcoholic steatohepatitis","volume":"288","author":"Kurniawan","year":"2018","journal-title":"J.\u00a0Contr. Release"},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12130_bib41","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1002\/hep.28680","article-title":"Inhibition of spleen tyrosine kinase activation ameliorates inflammation, cell death, and steatosis in alcoholic liver disease","volume":"64","author":"Bukong","year":"2016","journal-title":"Hepatology"},{"issue":"23","key":"10.1016\/j.heliyon.2022.e12130_bib42","doi-asserted-by":"crossref","first-page":"4512","DOI":"10.1038\/s41388-019-0734-5","article-title":"Targeting SYK signaling in myeloid cells protects against liver fibrosis and hepatocarcinogenesis","volume":"38","author":"Torres-Hernandez","year":"2019","journal-title":"Oncogene"},{"key":"10.1016\/j.heliyon.2022.e12130_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/1176934320943901","article-title":"Identification of hub genes and potential molecular mechanisms in patients with HBV-associated acute liver failure","volume":"16","author":"Sun","year":"2020","journal-title":"Evol. Bioinf. Online"},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12130_bib44","doi-asserted-by":"crossref","first-page":"95","DOI":"10.4103\/sjmms.sjmms_300_19","article-title":"Systematic analysis of spleen tyrosine kinase expression and its clinical outcomes in various cancers","volume":"8","author":"Alwithenani","year":"2020","journal-title":"Saudi J. Med. Med. Sci."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e12130_bib45","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.3748\/wjg.v26.i10.1005","article-title":"Role of spleen tyrosine kinase in liver diseases","volume":"26","author":"Kurniawan","year":"2020","journal-title":"World J. Gastroenterol."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12130_bib46","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10989-013-9390-8","article-title":"A\u00a0novel human Radixin peptide inhibits hepatitis C virus infection at the level of cell entry","volume":"20","author":"Bukong","year":"2014","journal-title":"Int. J. Pept. Res. Therapeut."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12130_bib47","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.ajpath.2020.03.014","article-title":"Phosphorylated Ezrin (Thr567) regulates Hippo pathway and yes-associated protein (Yap) in liver","volume":"190","author":"Xue","year":"2020","journal-title":"Am. J. Pathol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12130_bib48","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1002\/hep.26500","article-title":"Human ezrin-Moesin-Radixin proteins modulate hepatitis C virus infection","volume":"58","author":"Bukong","year":"2013","journal-title":"Hepatology"},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12130_bib49","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.ajpath.2018.02.013","article-title":"Hepatitis C virus Mimics effects of glypican-3 on CD81 and promotes development of hepatocellular carcinomas via activation of Hippo pathway in hepatocytes","volume":"188","author":"Xue","year":"2018","journal-title":"Am. J. Pathol."},{"issue":"Pt 5","key":"10.1016\/j.heliyon.2022.e12130_bib50","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1099\/vir.0.83510-0","article-title":"Hepatitis C virus NS5A protein interacts with and negatively regulates the non-receptor protein tyrosine kinase Syk","volume":"89","author":"Inubushi","year":"2008","journal-title":"J.\u00a0Gen. Virol."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12130_bib51","doi-asserted-by":"crossref","first-page":"3514","DOI":"10.1039\/C9FO00153K","article-title":"Mangiferin improves hepatic damage-associated molecular patterns, lipid metabolic disorder and mitochondrial dysfunction in alcohol hepatitis rats","volume":"10","author":"Li","year":"2019","journal-title":"Food Funct."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12130_bib52","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1002\/hep4.1269","article-title":"Inhibition of triggering receptor expressed on myeloid cells 1 ameliorates inflammation and macrophage and neutrophil activation in alcoholic liver disease in mice","volume":"3","author":"Tornai","year":"2019","journal-title":"Hepatol. Commun."},{"issue":"7","key":"10.1016\/j.heliyon.2022.e12130_bib53","doi-asserted-by":"crossref","first-page":"1524","DOI":"10.1111\/acer.13096","article-title":"Therapeutic benefits of spleen tyrosine kinase inhibitor administration on binge drinking-induced alcoholic liver injury, steatosis, and inflammation in mice","volume":"40","author":"Bukong","year":"2016","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.heliyon.2022.e12130_bib54","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/270302","article-title":"Functional roles of Syk in macrophage-mediated inflammatory responses","volume":"2014","author":"Yi","year":"2014","journal-title":"Mediat. Inflamm."},{"issue":"3","key":"10.1016\/j.heliyon.2022.e12130_bib55","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.bcp.2010.10.017","article-title":"Apoptosis of hepatic stellate cells mediated by specific protein nitration","volume":"81","author":"Modol","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.heliyon.2022.e12130_bib56","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.freeradbiomed.2021.08.241","article-title":"Dual inhibition of reactive oxygen species and spleen tyrosine kinase as a therapeutic strategy in liver fibrosis","volume":"175","author":"Hu","year":"2021","journal-title":"Free Radic. Biol. Med."},{"issue":"14","key":"10.1016\/j.heliyon.2022.e12130_bib57","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.18632\/oncotarget.27545","article-title":"Inhibition of SYK kinase does not confer a pro-proliferative or pro-invasive phenotype in breast epithelium or breast cancer cells","volume":"11","author":"Lamb","year":"2020","journal-title":"Oncotarget"},{"issue":"22","key":"10.1016\/j.heliyon.2022.e12130_bib58","doi-asserted-by":"crossref","first-page":"6687","DOI":"10.1158\/1078-0432.CCR-06-0921","article-title":"Frequent epigenetic inactivation of spleen tyrosine kinase gene in human hepatocellular carcinoma","volume":"12","author":"Yuan","year":"2006","journal-title":"Clin. Cancer Res."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12130_bib59","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/j.tranon.2019.04.023","article-title":"IL-17A increases multiple myeloma cell viability by positively regulating Syk expression","volume":"12","author":"Wang","year":"2019","journal-title":"Transl. Oncol."},{"issue":"5","key":"10.1016\/j.heliyon.2022.e12130_bib60","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1111\/jcmm.14927","article-title":"Effects of the multi-kinase inhibitor midostaurin in combination with chemotherapy in models of acute myeloid leukaemia","volume":"24","author":"Weisberg","year":"2020","journal-title":"J.\u00a0Cell Mol. Med."},{"issue":"12","key":"10.1016\/j.heliyon.2022.e12130_bib61","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1038\/labinvest.2014.118","article-title":"Downregulation of spleen tyrosine kinase in hepatocellular carcinoma by promoter CpG island hypermethylation and its potential role in carcinogenesis","volume":"94","author":"Shin","year":"2014","journal-title":"Lab. Invest."},{"issue":"6","key":"10.1016\/j.heliyon.2022.e12130_bib62","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1172\/JCI61380","article-title":"CHK1 targets spleen tyrosine kinase (L) for proteolysis in hepatocellular carcinoma","volume":"122","author":"Hong","year":"2012","journal-title":"J.\u00a0Clin. Invest."},{"issue":"10","key":"10.1016\/j.heliyon.2022.e12130_bib63","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1002\/1878-0261.12783","article-title":"Platelets are recruited to hepatocellular carcinoma tissues in a CX3CL1-CX3CR1 dependent manner and induce tumour cell apoptosis","volume":"14","author":"Miao","year":"2020","journal-title":"Mol. Oncol."},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12130_bib64","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1080\/09168451.2020.1756733","article-title":"Transcriptome alterations in HepG2 cells induced by shRNA knockdown and overexpression of TMEM2 gene","volume":"84","author":"Jia","year":"2020","journal-title":"Biosci. Biotechnol. Biochem."},{"issue":"2","key":"10.1016\/j.heliyon.2022.e12130_bib65","first-page":"170","article-title":"Recruitment of monocytes\/macrophages in different tumor microenvironments","volume":"1835","author":"Lee","year":"2013","journal-title":"Biochim. Biophys. Acta"},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12130_bib66","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1186\/s12929-019-0568-z","article-title":"Tumor-associated macrophages: an accomplice in solid tumor progression","volume":"26","author":"Chen","year":"2019","journal-title":"J.\u00a0Biomed. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2022.e12130_bib67","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"issue":"8","key":"10.1016\/j.heliyon.2022.e12130_bib68","doi-asserted-by":"crossref","first-page":"3614","DOI":"10.1021\/jm201271b","article-title":"Discovery and development of spleen tyrosine kinase (SYK) inhibitors","volume":"55","author":"Singh","year":"2012","journal-title":"J.\u00a0Med. Chem."},{"issue":"20","key":"10.1016\/j.heliyon.2022.e12130_bib69","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1016\/j.bmcl.2015.08.037","article-title":"Orally bioavailable Syk inhibitors with activity in a rat PK\/PD model","volume":"25","author":"Thoma","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.heliyon.2022.e12130_bib70","doi-asserted-by":"crossref","first-page":"78","DOI":"10.3389\/fimmu.2016.00078","article-title":"Targeting Syk in autoimmune rheumatic diseases","volume":"7","author":"Deng","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.heliyon.2022.e12130_bib71","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.3389\/fimmu.2018.01457","article-title":"Role of hepatic deposited immunoglobulin G in the pathogenesis of liver damage in systemic lupus erythematosus","volume":"9","author":"Fang","year":"2018","journal-title":"Front. Immunol."},{"issue":"4","key":"10.1016\/j.heliyon.2022.e12130_bib72","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1016\/j.ajpath.2017.12.010","article-title":"Spliceosome-associated protein 130 exacerbates alcohol-induced liver injury by inducing NLRP3 inflammasome-mediated IL-1beta in mice","volume":"188","author":"Kim","year":"2018","journal-title":"Am. J. Pathol."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022034181?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844022034181?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T13:41:54Z","timestamp":1767102114000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844022034181"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":72,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2405844022034181"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12130","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The spleen tyrosine kinase (SYK): A crucial therapeutic target for diverse liver diseases","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2022.e12130","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e12130"}}